p53 Protein Overexpression in Early Stage Endometrial Cancer

Author： Kohlberger P. Gitsch G. Loesch A. Tempfer C. Kaider A. Reinthaller A. Kainz C. Breitenecker G.

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.62, Iss.2, 1996-08, pp. : 213-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p53 Overexpression as a Prognostic Factor for Advanced Stage Bladder Cancer

By Kuczyk M.A. Bokemeyer C. Serth J. Hervatin C. Oelke M. Hofner K. Tan H.K. Jonas U.

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2243-2247

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of p53 Protein Expression in Early Gastric Cancer

By Gonçalves Andrea

Pathology & Oncology Research, Vol. 17, Iss. 2, 2011-06 ,pp. : 349-355

Springer Publishing Company

Access to resources Recommend Favorite

p53 as a Prognostic Indicator in Endometrial Cancer

By Geisler J.P. Wiemann M.C. Zhou Z. Miller G.A. Geisler H.E.

Gynecologic Oncology, Vol. 61, Iss. 2, 1996-05 ,pp. : 245-248

Academic Press

Access to resources Recommend Favorite

Cost-Effectiveness of Treatment of Early Stage Endometrial Cancer

By Ashih H. Gustilo-Ashby T. Myers E.R. Andrews J. Clarke-Pearson D.L. Berry D. Berchuck A.

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 208-216

Elsevier

Access to resources Recommend Favorite

Multidisciplinary Treatment of Early Stage Endometrial Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 6, 2013-07 ,pp. : 861-871

Bentham Science Publishers

Access to resources Recommend Favorite